Ann Arbor / Houston / Seoul / Cambridge / Foster City / Darmstadt / San Diego / San Jose / Santa Cruz / /
Company
ROS / Nanotechnology Laboratory / Cayman Chemical Co. / Becton Dickinson / Santa Cruz Biotechnology Inc. / BD Biosciences / Suzuki / Macmillan Publishers Limited / /
Country
Germany / United States / Canada / Korea / United Kingdom / / /
Event
Product Issues / /
Facility
The University of Texas MD Anderson Cancer Center / The University of Texas / Texas A&M University Health Science Center / SOM University of Pennsylvania / Institute of Biosciences / / /
IndustryTerm
active site / cancer therapy / image processing program / activation site / treatment of cancer / Treatment of Cell Death and Disease / coupled chemical reactions / metabolic network / /
MedicalCondition
dysfunction / solid tumors / POLGdn-induced mitochondrial respiratory dysfunction / human diseases / prostate cancer / tumor / mitochondrial dysfunction / I deficiency / cancer / Disease / mitochondrial respiratory dysfunction / respiratory dysfunction / mitochondrial respiration dysfunction / human disease / /
MedicalTreatment
chemotherapy / molecular therapies / cancer therapy / /
OperatingSystem
Petros / /
Organization
Institute of Biosciences and Technology / Department of Molecular Pathology / Texas A&M University Health Science Center / Anderson Cancer Center / U.S. Securities and Exchange Commission / Department of Genetics / CLL / University of Pennsylvania / Philadelphia / University of Texas / /
ZNF143 transcription factor mediates cell survival through upregulation of the GPX1 activity in the mitochondrial respiratory dysfunction